Audit 333987

FY End
2024-06-30
Total Expended
$7.59M
Findings
0
Programs
20
Year: 2024 Accepted: 2024-12-19
Auditor: Kpmg LLP

Organization Exclusion Status:

Checking exclusion status...

Contacts

Name Title Type
D529MMWMNHW3 Clinton Yee Auditee
8086911000 Amy Banovich Auditor
No contacts on file

Notes to SEFA

Accounting Policies: The accompanying schedule of expenditures of federal awards includes the federal grant activity of The Queen’s Health Systems and its subsidiaries (QHS) and is presented on the accrual basis of accounting. The information in this schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Therefore, some amounts presented in this schedule may differ from amounts presented in, or used in preparation of, the basic consolidated financial statements. De Minimis Rate Used: N Rate Explanation: For the Research and Development Cluster, QHS did not elect to use the 10% de minimis indirect cost rate as discussed in the Uniform Guidance Section 200.414 as QHS has a negotiated rate with the United States Department of Health and Human Services for the year ended June 30, 2024.